HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
 15,370
 -220 (-1.41%)
  Oct 31, 2025, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 215.83 billion as of October 31, 2025. Its market cap has decreased by -41.11% in one year.
Market Cap 
 215.83B
Enterprise Value 
 203.48B
Revenue 
 36.10B
Ranking 
 n/a
PE Ratio 
 456.63
Stock Price 
15,370.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 215.83B, an increase of 156.09%. That is a compound annual growth rate of 10.00%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 218.92B | -35.31% | 
| Dec 30, 2024 | 338.42B | 58.45% | 
| Dec 28, 2023 | 213.58B | 43.49% | 
| Dec 29, 2022 | 148.85B | -21.48% | 
| Dec 30, 2021 | 189.57B | -21.05% | 
| Dec 30, 2020 | 240.12B | 219.34% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
| Dec 21, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 9.08T | 
| Yuhan | 8.94T | 
| HLB Co., Ltd. | 6.25T | 
| Peptron | 6.06T | 
| PharmaResearch | 5.57T |